Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

YNIOS Pharma 3A

Equity
Key Investment Information Sheet Terms & Conditions
€56,000
total amount raised in round
6 days
remaining
  • Eligible for a tax reduction
Invest now
4 calendar day reflection period

Kevin G

Hi - Can you disclose the valuation of the Spreds 1A first round?

Thank you.

Kevin G

Next to the spreds compartiment and grants, how much was raised via other channels in the past 2 years?

Jean P

Dear Sir,
The company raised 500.000 EUR from private insvestors outsie of SPREDS.
Let me correct my previous answer, the amount raised by SPREDS in the first round was 105.000 EUR and not 205.000 EUR. The company also received another 10.300 EUR from SPREDS' investors in preferential rights adjustments.
Kind regards
JF Plucker

Jean P

Dear Kevin, YNIOS Pharma just held its board meeting and its shareholders' annual meeting. You may be interested to know that both assemblies have decided to entrust an expert to proceed with the valuation of the company. As a reminder, the company's current valuation reflects its number of shares of 1 EUR each, i.e. just above 6M€. The new valuation will take into account the market value of the R&D programs and of the patents and patents pending of the company.. This new evaluation will create a premium for each share which may multiply the value of the share by a factor, possibly between 2 to 10. This will have been the first value jump of the company. The company will post its new value and share premium when the process is completed. So hang-on and wait a few more weeks. It will be worth it !
Kind regards
JF Plucker

Kevin G

Thank you very much for your swift reply.

Jean P

Dear Sir,
205.000 EUR were raised by Spreds in the first round.
I hope this answers your question.
Best regards
JF Plucker

TAX SHELTER 45%

Investments in this company benefit from a 45% personal income tax reduction. Read more…
A remaining amount of €25,400 is available for the Tax Shelter benefit.

Fact sheet

Advised by a professional start-up advisor
Valuation is set by the co-investor or incubator
Co-investor or incubator will be members or observers to the board
At the closing, an incubator, accelerator, or studio will have shares
At the closing, the entrepreneurs have contributed a minimum of €15,000 in cash in exchange for shares
Raised €10,000 during a private phase
At the closing, a professional co-investor will have invested at least €25,000
Prior fundraising in equity or convertible loan with 10 or more investors
Seasoned entrepreneurs
Minimum 2 active entrepreneurs
Valuation set by an organisation specialized in valuations of comparable size
Valuation is less than €1 million or 10x last year’s turnover

Raise summary

Crowd investments €56,000
Committed by others €0
Amount raised €56,000
Minimum round €25,000
Maximum round €300,000
Shares in the company (total round) 4.773%
Pre-money valuation €5,985,300
Post-money valuation min. €6,010,300
Post-money valuation max. €6,285,300